Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
49 hedge funds and large institutions have $29.5M invested in Vaxxinity, Inc. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 3 reducing their positions, and 15 closing their positions.
433% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 3
56% more capital invested
Capital invested by funds: $18.9M → $29.5M (+$10.6M)
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
2% more funds holding
Funds holding: 48 → 49 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.23M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.39M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$860K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$598K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$477K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$618K |
| 2 |
Millennium Management
New York
|
-$481K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$285K |
| 4 |
Goldman Sachs
New York
|
-$217K |
| 5 |
HF
HRT Financial
New York
|
-$157K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Goldman Sachs
New York
| – | -$217K | -95,575 | Closed |
|
|
HF
52
HRT Financial
New York
| – | -$157K | -69,315 | Closed |
|
53
Squarepoint
New York
| – | -$118K | -51,941 | Closed |
|
54
Jane Street
New York
| – | -$99.3K | -43,730 | Closed |
|
55
Balyasny Asset Management
Chicago,
Illinois
| – | -$82.5K | -36,344 | Closed |
|
|
LP
56
LMR Partners
London,
United Kingdom
| – | -$71.3K | -31,389 | Closed |
|
|
CGL
57
Clarius Group LLC
Seattle,
Washington
| – | -$45.4K | -20,000 | Closed |
|
58
Two Sigma Investments
New York
| – | -$40.4K | -17,796 | Closed |
|
|
VF
59
Virtu Financial
New York
| – | -$28K | -12,263 | Closed |
|
|
ECM
60
ExodusPoint Capital Management
New York
| – | -$27K | -11,782 | Closed |
|
|
IWC
61
Integrated Wealth Concepts
Waltham,
Massachusetts
| – | -$25K | -11,000 | Closed |
|
|
CSS
62
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$22.6K | -9,971 | Closed |
|
63
Point72 Asset Management
Stamford,
Connecticut
| – | -$6.99K | -3,077 | Closed |
|
|
ASN
64
Advisory Services Network
Atlanta,
Georgia
| – | -$1.36K | -600 | Closed |
|
VAXX Hedge Fund Activity: Q2 2023 in Review
49 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q2 2023, worth a combined $29.5M — up 56% from $18.9M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new VAXX positions and 15 closed out — a net gain of 2 holders — while 16 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, adding an estimated $4.23M. The largest seller was Susquehanna International Group, cutting an estimated $618K.
- 49 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q2 2023, up from 48 in Q1 2023.
- Funds reported $29.5M of Vaxxinity, Inc. Class A Common Stock stock for Q2 2023, up 56% quarter-over-quarter.
- 17 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q2 2023 and 15 closed out, a net change of +2 holders.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q2 2023 was BlackRock, an estimated $4.23M added.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q2 2023 was Susquehanna International Group, an estimated $618K sold.
Based on aggregated 13F filings for Q2 2023.